Should herbal medicine-like products be licensed as medicines.
作者信息
De Smet P A
出版信息
BMJ. 1995 Apr 22;310(6986):1023-4. doi: 10.1136/bmj.310.6986.1023.
Abstract
摘要
相似文献
1
Should herbal medicine-like products be licensed as medicines.
BMJ. 1995 Apr 22;310(6986):1023-4. doi: 10.1136/bmj.310.6986.1023.
2
[Review on community herbal monographs for traditional herbal medicinal products].[传统草药产品的社区草药专论综述]
Zhongguo Zhong Yao Za Zhi. 2011 Dec;36(23):3386-8.
3
Drug safety aspects of herbal medicinal products.草药产品的药物安全性方面
Wien Med Wochenschr. 2015 Jun;165(11-12):243-50. doi: 10.1007/s10354-015-0370-9. Epub 2015 Jul 17.
4
[Requirements for quality of approved plant medicines].[已批准植物药的质量要求]
Ther Umsch. 2002 Jun;59(6):267-73. doi: 10.1024/0040-5930.59.6.267.
5
The Brazilian market of herbal medicinal products and the impacts of the new legislation on traditional medicines.巴西草药药品市场与新法规对传统药物的影响。
J Ethnopharmacol. 2018 Feb 15;212:29-35. doi: 10.1016/j.jep.2017.09.040. Epub 2017 Oct 4.
6
The use of community herbal monographs to facilitate registrations and authorisations of herbal medicinal products in the European Union 2004-2012.2004 - 2012年欧盟利用社区草药专论促进草药产品注册与授权情况
J Ethnopharmacol. 2014 Dec 2;158 Pt B:471-86. doi: 10.1016/j.jep.2014.07.015. Epub 2014 Jul 17.
7
Monographs, list entries, public statements.专著、列表条目、公开声明。
J Ethnopharmacol. 2014 Dec 2;158 Pt B:458-62. doi: 10.1016/j.jep.2014.08.033. Epub 2014 Sep 3.
8
Botanical medicines--the need for new regulations.植物药——新法规的必要性
N Engl J Med. 2002 Dec 19;347(25):2073-6. doi: 10.1056/NEJMsb022858.
9
The licensing of medicines in the UK.英国药品的许可情况。
Drug Ther Bull. 2009 Apr;47(4):45-8. doi: 10.1136/dtb.2009.03.0012.
10
Medicines from plants with special reference to herbal products in Great Britain.
Planta Med. 1987 Apr;53(2):121-3. doi: 10.1055/s-2006-962651.
引用本文的文献
1
Contribution of Ethnomedical Use Data to the Marketing Authorization of Traditional Herbal Medicines in Mali.民族医学使用数据对马里传统草药药品上市许可的贡献。
Glob Adv Integr Med Health. 2024 Oct 24;13:27536130241296823. doi: 10.1177/27536130241296823. eCollection 2024 Jan-Dec.
2
Legal regulations of complementary and alternative medicines in different countries.不同国家补充和替代医学的法律法规。
Pharmacogn Rev. 2012 Jul;6(12):154-60. doi: 10.4103/0973-7847.99950.
3
Over the counter (OTC) oral remedies for arthritis and rheumatism: how effective are they?非处方（OTC）口腔关节炎和风湿病药物：它们的疗效如何？
Inflammopharmacology. 1999;7(2):89-105. doi: 10.1007/BF02918382.
4
Syncope and atypical chest pain in an intercollegiate wrestler: a case report.大学生摔跤运动员晕厥和非典型胸痛：病例报告。
J Athl Train. 1999 Jul;34(3):263-6.
5
The role of plant-derived drugs and herbal medicines in healthcare.植物源药物和草药在医疗保健中的作用。
Drugs. 1997 Dec;54(6):801-40. doi: 10.2165/00003495-199754060-00003.
6
Pharmacokinetic evaluation of herbal remedies. Basic introduction, applicability, current status and regulatory needs.草药疗法的药代动力学评估。基本介绍、适用性、现状及监管需求。
Clin Pharmacokinet. 1997 Jun;32(6):427-36. doi: 10.2165/00003088-199732060-00001.
7
St John's wort as an antidepressant.圣约翰草作为一种抗抑郁药。
BMJ. 1996 Aug 3;313(7052):241-2. doi: 10.1136/bmj.313.7052.241.
8
Monitoring the safety of herbal remedies. European pilot studies are under way.监测草药疗法的安全性。欧洲的试点研究正在进行中。
BMJ. 1995 Dec 9;311(7019):1570. doi: 10.1136/bmj.311.7019.1570.
9
Safety of complementary medicines should be monitored.辅助药物的安全性应受到监测。
BMJ. 1995 Sep 2;311(7005):633. doi: 10.1136/bmj.311.7005.633b.
10
Should herbal medicines be licensed?草药应该被许可吗？
BMJ. 1995 Aug 12;311(7002):451-2. doi: 10.1136/bmj.311.7002.451c.
本文引用的文献
1
An introduction to herbal pharmacoepidemiology.草药药物流行病学导论。
J Ethnopharmacol. 1993 Mar;38(2-3):197-208. doi: 10.1016/0378-8741(93)90016-x.
2
Towards the safer use of traditional remedies.迈向传统疗法的更安全使用。
BMJ. 1994 Mar 12;308(6930):673-4. doi: 10.1136/bmj.308.6930.673.
3
Potential risks of health food products containing yohimbe extracts.含有育亨宾提取物的健康食品的潜在风险。
BMJ. 1994 Oct 8;309(6959):958. doi: 10.1136/bmj.309.6959.958.
4
Potentially hazardous compound in a herbal slimming remedy.
Lancet. 1992 Jul 18;340(8812):179. doi: 10.1016/0140-6736(92)93257-n.
Zotero 插件